Acupressure Therapy for Lessening Fatigue in Ovarian Cancer Survivors

Status: closed to accrual

This trial studies how well acupressure works in lessening fatigue in ovarian cancer survivors. Acupressure involves applying mild to moderate physical pressure by fingers, hand or a device to specific points on the skin to try to bring about a physiological change in the body, in this case relief from chronic fatigue.

Inclusion Criteria

Women aged 21 years and older
Diagnosis of ovarian cancer stages I to IV.
Have average persistent fatigue defined as >= 4 on the Brief Fatigue Inventory
Fatigue must have started at or after the diagnosis of ovarian cancer.
Completed all primary cancer treatments (surgery, chemotherapy at least 6 months prior), except maintenance therapies.
No other planned interventions for fatigue other than current stable medication.

Exclusion Criteria

Medically unstable.
Acupuncture or acupressure receipt in past year.
Have a diagnosis of untreated mood disorder, e.g., bipolar or major depressive disorder.
Have a current diagnosis of anemia.
Have a current untreated diagnosis of hypothyroidism.
Have an initiation, a cessation or change of treatment of any chronic medications, dietary supplements, behavioral therapy, physical therapy etc., or any planned change of medications, supplements or therapies during the study.
Have the possibility of becoming pregnant.
Diagnosis of coronavirus disease 2019 (COVID-19) on or after 3/1/2020 with fatigue onset following diagnosis.

PRIMARY OBJECTIVES:

I. Examine the effect of 6 weeks of daily self-administered relaxing acupressure compared to self-administered sham acupressure or no treatment on: persistent fatigue.

SECONDARY OBJECTIVES:

I. Examine the effect of 6 weeks of daily self-administered relaxing acupressure compared to self-administered sham acupressure or no treatment on: quality of life.

II. Examine the effect of 6 weeks of daily self-administered relaxing acupressure compared to self-administered sham acupressure or no treatment on: sleep quality.

EXPLORATORY OBJECTIVES:

I. Examine the effect of 6 weeks of daily self-administered relaxing acupressure compared to self-administered sham acupressure or no treatment on: symptoms commonly associated with persistent fatigue (sleep disturbance, pain, cognitive function, mood, and female sexual function).

II. To investigate the duration of effect self-administered relaxing acupressure as compared to self-administered sham acupressure or no treatment during the 18 weeks following the end of acupressure treatment (carry-over phase) on persistent fatigue, quality of life, sleep quality, and symptoms commonly associated with persistent fatigue (sleep disturbance, pain, cognitive function, mood, and female sexual function) using the measurement tools described for the primary aim.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I: Patients receive relaxing acupressure on 9 acupoints daily for a total of 27 minutes using the AcuWand and the modified MeTime Acupressure mobile application.

ARM II: Patients receive sham acupressure on 9 acupoints daily for a total of 27 minutes using the AcuWand and the modified MeTime Acupressure mobile application.

ARM III: Patients receive no treatment.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.

Acupressure Therapy for Lessening Fatigue in Ovarian Cancer Survivors

Description

Eligibility Criteria

Locations & Contacts

Trial Objectives and Outline

Trial Phase & Type

Lead Organization

Trial IDs

Have a question?We're here to help

Which trials are right for you?

Have a question?
We're here to help